ArticlePDF Available

Natural Herbs as Anticancer Drugs

Authors:
  • Parul Institute of Pharmacy and Research

Abstract

This article has been made to review some medicinal plants used for the treating cancer disease . The plant sources of India are likely to provide effective anticancer agents. Herbs have a vital role in the prevention and treatment of cancer. Examples are provided in this review of promising bioactive compounds obtained from various plants with medicinal and other therapeutic uses. The photochemical exploration of these herbs has contributed to some extent in this race for the discovery of new anticancer drugs. In recent years owing to the fear of side effects people prefer to use of natural plant products for cancer treatment. This review also helps to summarize the diverse methodologies and various ways to evaluate the potential natural compounds having anticancer activity. Although drug discovery from medicinal plants continues to provide an important source of new drug leads, numerous challenges are encountered including the procurement of plant materials and their selection.
International Journal of PharmTech Research
CODEN (USA): IJPRIF ISSN : 0974-4304
Vol.4, No.3, pp 1142-1153, July-Sept 2012
Natural Herbs as Anticancer Drugs
Nidhi Agarwal1* ,Chandana Majee1, G. S. Chakraborthy1
1Department of Pharmaceutical Technology, Noida Institute of Engineering
&Technology, 19, Knowledege Park-II, Greater Noida, Uttar Pradesh-201 306, India
*Corres Author: nidhinov07@gmail.com
Phone No: +919411824781
Abstract: This article has been made to review some medicinal plants used for the treating cancer disease .
The plant sources of India are likely to provide effective anticancer agents. Herbs have a vital role in the
prevention and treatment of cancer. Examples are provided in this review of promising bioactive compounds
obtained from various plants with medicinal and other therapeutic uses. The photochemical exploration of these
herbs has contributed to some extent in this race for the discovery of new anticancer drugs. In recent years
owing to the fear of side effects people prefer to use of natural plant products for cancer treatment. This review
also helps to summarize the diverse methodologies and various ways to evaluate the potential natural
compounds having anticancer activity. Although drug discovery from medicinal plants continues to provide an
important source of new drug leads, numerous challenges are encountered including the procurement of plant
materials and their selection.
Keywords: Medicinal plants, Anticancer agents, Bioactive compounds.
Introduction
Cancer is a leading cause of mortality, and it strikes
more than one-third of the world’s population and
it’s the cause of more than 20% of all deaths.
Among the causes for cancer are tobacco , viral
infection, chemicals, radiation, environmental
factors, and dietary factors.1Surgery, chemotherapy
and radiotherapy are the main conventional cancer
treatment often supplemented by other
complementary and alternative therapies in China.2
Plants has been used as an age old remedy of cancer
history of use in the treatment of cancer. Extensive
research at Sandoz laboratories in Switzerland in the
1960s and 1970s led to the development of
etoposide and teniposide as clinically effective
agents which are used in the treatment of
lymphomas, bronchial and testicular cancer.3These
plants may promote host resistance against infection
by re-stabilizing body equilibrium and conditioning
the body tissues. Several reports describe that the
anticancer activity of medicinal plants is due to the
presence of antioxidants present in them. In fact, the
medicinal plants are easily available, cheaper and
possess no toxicity as compared to the modern
(allopathic) drugs.4The development of novel plant-
derived natural products and their analogs for
anticancer activity details efforts to synthesize new
derivatives based on bioactivity- and mechanism of
action-directed isolation and characterization
coupled with rational drug design - based
modification.5
Oncogenes are regulators of cellular communication
with the outside environment. They are derived
through the mutation of proto-oncogenes. Mutated
oncogenes are stimulated by exposure to chemical,
environment or viral carcinogens, which leads to cell
changes and they produce proteins which are
either wrongly expressed within their normal cell or
expressed in inappropriate tissue which leads to
cellular proliferation and there by result in cancer
formation . Tumor suppressor genes are intended to
keep oncogenes in check by halting uncontrolled
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1143
cellular growth. In direct opposition to oncogenes,
which induce cancer when stimulated or amplified,
tumor suppressor genes promote cancer when
inactivated or attenuated. Two of the most prevalent
tumor suppressor genes involved in the generation of
cancer are p53 and retinoblastoma or Rb.6
Anticancer Plants
Acronychia Bauer:-Utilizing a differential extraction
technique for the examination of the bark of the
Australian plant Acronychia Baueri Schott
(Bauerella australiana Borzi), has resulted in the
isolation of the triterpene lupeol and the alkaloids
melicopine, acronycine, and normelicopidine. The
experimental anti tumor activity associated with the
crude alkaloidal mixture obtained from the ether
extract has been shown to be attributable to
acronycine. Experimental evidence is herein given,
showing acronycine to have the broadest antitumor
spectrum of any alkaloid isolated to date in these
laboratories. By virtue of its being chemically
unrelated to any of the presently utilized antitumor
agents it represents a new lead in the search for
agents effective in the chemotherapeutic
management of human neoplasms.7
Garlic (Allium sativum L.) has a long history of
being as a food having a unique taste and odor
along with some medicinal qualities. Modern
scientific research has revealed that the wide variety
of dietary and medicinal functions of garlic can be
attributed to the sulfur compounds present in or
generated from garlic. Although garlic produces
more than 20 kinds of sulfide compounds from a few
sulfur-containing amino acids, their functions are
different from one another; e.g., allicin, methyl allyl
trisulfide, and diallyl trisulfide have antibacterial,
antithrombotic, and anticancer activities,
respectively.8
Garlic [Allium sativum] is among the oldest of all
cultivated plants. It has been used as a medicinal
agent for thousands of years. It is a remarkable plant,
which has multiple beneficial effects such as
antimicrobial, antithrombotic, hypolipidemic,
antiarthritic, hypoglycemic and antitumor activity. A
number of studies have demonstrated the
chemopreventive activity of garlic by using different
garlic preparations including fresh garlic extract,
aged garlic, garlic oil and a number of organosulfur
compounds derived from garlic. The
chemopreventive activity has been attributed to the
presence of organosulfur compounds in garlic.
However it not understood, but several mode of
action this is achieved is not fully understood, but
several modes of action have been proposed. These
include its effect on drug metabolizing enzymes,
antioxidant properties and tumor growth inhibition.
Most of these studies were carried out in the animal
models. Also, recent research has been focused on
the antimutagenic activity of garlic. Recently, it has
been observed that aged garlic extract, but not the
fresh garlic extract, exhibited free radical
scavenging activity. The two major compounds in
aged garlic, S-allylcysteine and S-allylmercapto-L-
cysteine, which has had the highest radical
scavenging activity. In addition, some organosulfur
compounds derived from garlic, include S-
allylcysteine, have been found to retard the growth
of chemically induced and transplantable tumors in
several animal models. Therefore, the consumption
of garlic may provide some kind of protection from
cancer development.9
Table No.1:Types of cancer and common oncogenic or tumor suppressor gene origin .
Cancer type
Common oncogenic or tumor suppressor
gene origin
Chronic myelogenous leukemia
Bcr-abl proto-oncogene translocation
Follicular lymphoma
Bcl-2 amplification, myc mutation
Sporadic thyroid cancer
Ret mutation
Colorectal and gastric cancer
APC gene mutation
Familial breast and ovarian cancer
BRCA1, BRCA2 mutation
Invasive ductal breast cancer
HER-2 amplification
Familial melanoma
P16INK4A mutation
Childhood neuroblastoma and small cell lung
cancer
N-myc amplification
Leukemia, breast, colon, gastric and lung
cancer
c-MYC amplification
Renal cell cancer
Von Hippel-Lindaugene (VHL) dysfunction
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1144
Artemisia capillaries is a major important food and
medicinal resource found in Korea. In order to
confirm the biological activities of Artemisia
capillaries, antioxidant and anticancer activities
from in vitro assays were investigated. The
Artemisia capillaries methanol (MeOH) extracts
were used for the evaluation of DPPH(2,2-diphenyl-
1-picrylhydrazyl) scavenging, total phenolic content,
total flavonoid content, hydroxyl radical (OH)
scavenging, reducing power assay as antioxidant
activity, as well as anticancer activities as MTT
assay. As a result, the Artemisia capillaries MeOH
extracts showed potent antioxidative activity and
anticancer activity in vitro. These results suggest
that the Artemisia capillaries MeOH extracts have a
potential alleviated oxidation process, cell motility
activity, and tumorigenesis. 10
Astragalus membranaceus, a commonly used
Chinese medicinal plant, has been shown to be
capable of restoring the impaired T cell functions in
cancer patients. The in vitro and in vivo anti-tumor
effects of A. membranaceus were investigated. Five
bioactive fractions were isolated from the root of A.
membranaceus, the fraction designated as AI was
found to be the most potent among the five fractions
with respect to its mitogenicity on murine
splenocytes. Besides investigating the cytostatic
effect of AI, its activities on macrophage function,
tumor necrosis factor production, induction of
lymphokine-activated killer cell and tumor cell
differentiation were also examined. The
macrophage-like tumors and the myeloid tumors
were found to be more sensitive to the cytostatic
activity of AI, whereas the fibroblast-like tumors
and the mouse Ehrlich ascites tumor appeared to be
relatively resistant. Moreover, AI could effectively
suppress the in vivo growth of syngeneic tumor in
mice. Results showed that murine macrophage
pretreated with AI had increased in vitro and in vivo
cytostatic activities towards MBL-2 tumor. AI could
also act as a priming agent for tumor necrosis factor
production in tumor-bearing mice. Preincubation of
mouse splenocytes with AI could induce in vitro
lymphokine-activated killer-like activity towards
WEHI-164 cell. Furthermore, AI was able to induce
monocytic differentiation of both human and murine
cells in vitro. AI administered in vivo could even
partially restore the depressed mitogenic response in
tumor-bearing mice. Collectively, the results showed
that A. membranaceus could exhibit both in vitro
and in vivo anti-tumor effects, which might be
achieved through activating the anti-tumor immune
mechanism of the host.11
The in vitro inhibitory effect of Beta vulgaris (beet)
root extract on Epstein-Barr virus early antigen
(EBV-EA) induction using Raji cells revealed a high
order of activity compared to capsanthin, cranberry,
red onion skin and short and long red bell peppers.
An in vivo anti-tumor promoting activity evaluation
against the mice skin and lung bioassays also
revealed a significant tumor inhibitory effect. The
combined findings suggest that beetroot ingestion
can be one of the useful means to prevent cancer. 12
Green tea is an aqueous infusion of dried
unfermented leaves of Camellia sinensis (Family
Theaceae) from which numerous biological
activities have been reported including
antimutagenic, antibacterial, hypocholesterolemic,
antioxidant, antitumor and cancer preventive
activities. From the aqueous-alcoholic extract of
green tea leaves, six compounds (+)-gallocatechin
(GC), (-)-epicatechin (EC), (-)-epigallocatechin
(EGC), (-)-epicatechin gallate (ECG), (-)-
epigallocatechin gallate (EGCG) and caffeine, were
isolated and purified. Together with (+)-catechin,
these compounds were tested against each of four
human tumor cells lines (MCF-7 breast carcinoma,
HT-29 colon carcinoma, A-427 lung carcinoma and
UACC-375 melanoma). The three most potent green
tea components against all four tumor cell lines were
EGCG, GC and EGC. EGCG was the most potent of
the seven green tea components against three out of
the four cell lines (i.e. MCF-7 breast cancer, HT-29
colon cancer and UACC-375 melanoma). On the
basis of these extensive in vitro studies, it would be
of considerable interest to evaluate all three of these
components in comparative preclinical in vivo
animal tumor model systems before final decisions
are made concerning which of these potential
chemopreventive drugs should be taken into broad
clinical trials. 13
Camptothecin (CPT) is an anticancer and antiviral
alkaloid produced by the Chinese tree Camptotheca
acuminata (Nyssaceae) and some other species
belonging to the families Apocynaceae, Olacaceae,
and Rubiaceae. Bark and seeds are currently used as
sources for the drug. Several attempts have been
made to produce CPT from cell suspensions;
however, the low yields obtained limit this approach.
Cultures of differentiated cell types may be an
alternative source of alkaloid production. Hairy root
cultures of C. acuminata were established from
tissue transformed with Agrobacterium rhizogenes
strains ATCC 15834 and R-1000. Integration of
these genes are responsible for the hairy-root
phenotype (rol genes) into the plant genome was
verified by DNA gel blot analysis. The hairy roots
produce and secrete CPT as well as the more potent
and less toxic natural derivative, 10-
hydroxycamptothecin (HCPT), into the medium.
Remarkably, the cultures were able to synthesize the
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1145
alkaloids at levels equal to, and sometimes greater
than, the roots in planta, i.e., 1.0 and 0.15 mg/g dry
weight for CPT and the HCPT, respectively.14
Catharanthus roseus produces low levels of two
dimeric terpenoid indole alkaloids, vinblastine and
vincristine, which are widely used in cancer
chemotherapy. The dimerization reaction leading to
α-3', 4’-anhydrovinblastine is a key regulatory step
for the production of the anticancer alkaloids in
planta has an potential application in the industrial
production of two semisynthetic derivatives also
used as anticancer drugs. The cloning,
characterization, and subcellular localization of an
enzyme with anhydrovinblastine synthase activity
identified as the major class III peroxidase present in
C. roseus leaves and was named an CrPrx1. The
deduced amino acid sequence corresponds to a
polypeptide of 363 amino acids including an N-
terminal signal peptide showing the secretory nature
of CrPrx1. CrPrx1 has a two-intron structure and is
present as a single gene copy. Phylogenetic analysis
indicates that CrPrx1 belongs to an evolutionary
branch of vacuolar class III peroxidases whose
members seem to have been recruited for different
functions during evolution. Expression of a green
fluorescent protein-CrPrx1 fusion confirmed the
vacuolar localization of this peroxidase, the exact
subcellular localization of the alkaloid monomeric
precursors and dimeric products. Expression data
further supports the role of CrPrx1 in α-3', 4’-
anhydrovinblastine biosynthesis, indicating the
potential of CrPrx1 as a target to increase alkaloid
levels in the plant.15
Inonotus obliquus :-The Chaga mushroom (Inonotus
obliquus) has been used in folk medicine to treat
cancers. However, limited information exists on the
underlying anticancer effects of the major
component of I. obliquus in vivo studies . It is
hypothesized that the pure compounds (3β-hydroxy-
lanosta-8, 24-dien-21-al, inotodiol and lanosterol,
respectively) isolated from I. obliquus would inhibit
tumor growth in Balbc mice bearing Sarcoma-180
cells (S-180) in vivo and growth of human
carcinoma cells in vitro. To test this hypothesis, the
growth inhibition of each subfraction isolated from
I. obliquus on human carcinoma cell lines (lung
carcinoma A-549 cells, stomach adenocarcinoma
AGS cells, breast adenocarcinoma MCF-7 cells, and
cervical adenocarcinoma HeLa cells) was tested in
vitro. Then, after S-180 implantation, the mice were
fed a normal chow supplemented with 0, 0.1 or 0.2
mg of subfraction 1, 2 or 3 per mouse per day. All of
the subfractions isolated from I. obliquus showed
significant cytotoxic activity against the selected
cancer cell lines in vitro. Subfraction 1 was more
active than subfraction 2 and subfraction 3 against
the A549, AGS and MCF-7 cancer cell lines in vitro.
In in vivo results, subfraction 1 isolated from I.
obliquus at concentrations of 0.1 and 0.2 mg/mouse
per day significantly decreased tumor volume by
23.96% and 33.71%, respectively, as compared with
the control. Subfractions 2 and 3 also significantly
inhibited tumor growth in mice bearing S-180 as
compared with the control mouse tumor. Subfraction
1 isolated from I. obliquus showed greater inhibition
of tumor growth than subfractions 2 and 3, which
agrees well with the in vitro results. The results
suggest that I. obliquus and its compounds in these
subfractions isolated from I. obliquus could be used
as natural anticancer ingredients in the food and/or
pharmaceutical industry.16
Anticancer activity of the rhizomes of turmeric
(Curcuma longa) was evaluated by italies in vitro
using tissue culture methods and in vivo in mice
using Dalton's lymphoma cells grown as ascites
form. Turmeric extract inhibited the cell growth in
Chinese Hamster Ovary (CHO) cells at a
concentration of 0.4 mg/ml and was cytotoxic to
lymphocytes and Dalton's lymphoma cells at the
same concentration. Cytotoxic effect was found
within 30 min at room temperature (30 C). The
active constituent was found to be 'curcumin' which
showed cytotoxicity to lymphocytes and Dalton's
lymphoma cells at a concentration of 4 mg/ml.
Initial experiments indicated that turmeric extract
and curcumin reduced the development of animal
tumours.17
Curcuma zedoaria belonging to the family
Zingiberaceae has been used in the traditional
system of medicine in India and Southwest Asia in
treating many human ailments and is found to
possess many biological activities. The rationale of
the present study was to isolate, identify, and
characterize antitumour principles from the rhizomes
of Curcuma zedoaria, to assess its cytotoxic effects
on human and murine cancer cells, to determine its
apoptosis inducing capacity in cancer cells, and to
evaluate its tumour reducing properties in in vivo
mice models. Isocurcumenol was characterized as
the active compound by spectroscopy and was found
to inhibit the proliferation of cancer cells without
inducing significant toxicity to the normal cells.
Fluorescent staining exhibited the morphological
features of apoptosis in the compound-treated cancer
cells. In vivo tumour reduction studies revealed that
a dose of 35.7mg/kg body weight significantly
reduced the ascitic tumour in DLA-challenged mice
and increased the lifespan with respect to untreated
control mice.18
Three constituents, β-sitosterol, laserine and
epilaserine, were isolated from the lipophilic fraction
of Daucus carota. Among the 3 constituents,
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1146
epilaserine showed significantly inhibitory effect on
leukemia cell, HL-60.19
Licochalcone (LA) is a novel estrogenic flavonoid
isolated from PC-SPES composition herb licorice
root (Glycyrrhiza Glabra) which show significant
antitumor activity in various malignant human cell
lines. To better understand its anti-Cancer activities
investigation were carried out in LA-elicited growth
control and induction of apoptosis using androgen-
independent p53-null PC-3 prostate cancer cells. LA
induced modest level of apoptosis but had more
pronounced effect on cell cycle progression arresting
cells in G2/M, accompanied by suppression of
cyclin B1 and cdc2. It also inhibited phosphorylation
of Rb, specifically phosphorylation of S780 with no
change of phosphorylation status of T821, decreased
expression of transcription factor E2F concurrent
with reduction of cyclin D1, down-regulation of
CDKs 4 and 6, but increased cyclin E expression.
These findings provide mechanistic explanation for
LA activity and suggest that it may be considered as
a chemopreventive agent and its anticancer
properties should be further explored.20
Ethanolic extract of Hydrastis canadensis has been
tested for its possible anti-cancer potentials against
p-dimethylaminoazobenzene (p-DAB) induced
hepatocarcinogenesis in mice. A critical analysis of
results of this investigation shows anti-cancer
potentials of the drug suitable for use as a supportive
complementary medicine in liver cancer.21
The aqueous extract of Larrea divaricata has an
antiproliferative activity on T lymphoma (BW 5147)
cells in culture. Moreover the extract has in vivo
antitumor activity when it was administered to a
pregnant rat which had a spontaneous mammary
tumor. The effect of an extract of Larrea divaricata
was studied on a mammary carcinoma chemically
induced with N-nitrosomethylurea in females rats.
The extract was administered at a dose of 250 mg/kg
three times each week by two different routes,
subcutaneous (s.c.) and intratumoral (i.t.). the
investigation shows that the aqueous extract of this
plant has an in vivo antitumor activity with the
intratumor route being most effective in induction of
tumor regression.22
The cytotoxicity effect of tomato (Lycopersicum
esculentum) leaves (methanol extract ) on cancer
cells to address potential therapeutic in MCF-7
breast cancer cell lines and its toxicity towards Vero
cells was shown. The effect of extract towards
MCF-7 breast cancer cell lines and Vero cells were
observed using in vitro cytotoxicity assay to indicate
its active fractions and its half maximal inhibitory
concentration (IC50). Purified sample gave a
rational effect towards MCF-7 breast cancer cells
with IC50 value of 5.85 μg mL-.23
Ginseng (Panax ginseng), which is traditionally used
in some parts of the world as a popular remedy for
various diseases including cancer. It was
hypothesized that the ginsenoside Rp1, a component
of ginseng, reduces cancer cell proliferation through
inhibition of the insulin-like growth factor 1 receptor
(IGF-1R)/Akt pathway. Firstly, the efficacy of Rp1
was tested against human breast cancer cell lines.
Treatment with Rp1 inhibited breast cancer cell
proliferation and inhibited both anchorage-
dependent and -independent breast cancer cell
colony formation. In addition, to it the treatment
with 20 μM Rp1 induced cycle arrest and apoptosis-
mediated cell growth suppression. Findings further
indicated that Rp1 decreased the stability of the IGF-
1R protein in breast cancer cells. Therefore, it is
suggest that Rp1 has potential as an anticancer drug
and that IGF-1R is an important target for treatment
and prevention of breast cancer .24
Roots of Pfaffia paniculata have been well
documented for multifarious therapeutic values and
have also been used for cancer therapy in folk
medicine. Study has been performed in a human
breast tumor cell line, the MCF-7 cells. These are
the most commonly used model of estrogen-positive
breast cancer, and it has been originally established
in 1973 at the Michigan Cancer Foundation from a
pleural effusion taken from a woman with metastatic
breast cancer. Butanolic extract of the roots of P.
paniculata showed cytotoxic effect MCF-7 cell line,
as determined with crystal violet assay, cellular
death with acridine orange/ethidium bromide
staining, and cell proliferation with
immunocytochemistry of bromodeoxyuridine
(BrdU). Subcellular alterations were evaluated by
electron microscopy. Cells treated with butanolic
extract showed degeneration of cytoplasmic
components and profound morphological and
nuclear alterations. The results show that this
butanolic extract indeed presents cytotoxic
substances, and its fractions merit further
investigations.25
The plant Podophyllum peltatum produces
podophllyotoxin, a resin, throughout the entire plant
but especially in the rhizome. It is produced as a
form of protection from insects and other herbivores.
When ingested it causes gastroenteritis or even
death in humans. Edema (swelling) and eventual
deterioration of the spinal cord, brainstem,
cerebellum, and cerebral cortex have been reported
in rats treated with various amounts of the toxin.
Toxicities of other organs (although not specifically
mentioned) have been documented
Historically, this plant was widely used as a Chinese
herbal medicine because it is a wild Asian plant. It
was used to treat snakebites, general weakness,
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1147
poisons, condyloma accuminata, lymphadenopathy,
and certain tumors. It was also used by the
Penobscot Indians to treat cancer.26
Three anthraquinones, Cdc25B phosphatase
inhibitors, were isolated from the methanolic extract
of the roots of Polygonum multiflorum Thunb.
(Polygonaceae). Anthraquinones, physcion ,
emodin, and questin , inhibited the enzymatic
activity of Cdc25B phosphatase with IC50 values of
62.5, 30, and 34µgmL−1, respectively. Emodin and
questin strongly inhibited the growth of human
colon cancer cells, SW620 with GI50 values of 6.1
and 0.9µgmL−1, respectively. Commercially
available anthraquinones, chrysophanol, and rhein
also inhibited Cdc25B phosphatase with IC50 values
of 10.7 and 22.1µgmL−1, respectively.27
Three toxic proteins and one agglutinin were
purified from the seeds of Ricinus communis by
simple and fast method using Sepharose 4-B affinity
chromatography followed by Sephadex G-100 gel
filtration. The weakly adsorbed ricins A and B were
retarded and eluted with the buffer from the affinity
chromatographic column, while ricin C and ricinus
agglutinin had to be eluted with 0.1 M galactose.
The molecular weights of ricins A, B, and C were
about 62,000 and that of ricinus agglutinin was
120,000, estimated by amino acid compositions and
SDS gel electrophoresis. They all possessed two
non-identical subunits: A and B chains linked by one
disulfide bond. Their LD50 values were 4, 28, 14
and 112 micrograms per kg body weight of mice for
ricins A, B and C and ricinus agglutinin,
respectively. The amino acid compositions of the
three toxins and their A and B subunits were very
similar, but not identical, while ricinus agglutinin
showed a different composition. Ricin A is a newly
isolated lectin which has a strong inhibitory effect
on the growth of tumor cells. By using cell cultures,
it was demonstrated that the tumor cells were more
sensitive to lectin than non-transformed cells, and
that this could be caused by the higher binding
affinity of lectin to tumor cells than to non-
transformed cells.28
Barley and wheat: Lunasin, a unique 43 amino acid,
4.8 kDa cancer-chemopreventive peptide initially
reported in soybean and now found in barley and
wheat, has been shown to be cancer-
chemopreventive in mammalian cells and in a skin
cancer mouse model against oncogenes and
chemical carcinogens. To identify bioactive
components in traditional herbal medicines and in
search for new sources of lunasin, we report here the
properties of lunasin from Solanum nigrum L.
(SNL), a plant indigenous to northeast Asia. Lunasin
was screened in the crude extracts of five varieties of
the medicinal plants of Solanaceae origin and seven
other major herbal plants. An in vitro digestion
stability assay for measuring bioavailability was
carried out on SNL crude protein and autoclaved
SNL using pepsin and pancreatin. A nonradioactive
histone acetyltransferase (HAT) assay and HAT
activity colorimetric assay were used to measure the
inhibition of core histone acetylation. The inhibitory
effect of lunasin on the phosphorylation of
retinoblastoma protein (Rb) was determined by
immunoblotting against phospho-Rb. Lunasin
isolated from autoclaved SNL inhibited core histone
H3 and H4 acetylation, the activities of the HATs,
and the phosphorylation of the Rb protein. Lunasin
in the crude protein and in the autoclaved crude
protein was very stable to pepsin and pancreatin in
vitro digestion, while the synthetic pure lunasin was
digested at 2 min after the reaction. It was conclude
that lunasin is a bioactive and bioavailable
component in SNL and that consumption of SNL
may play an important role in cancer prevention.29
Solanum nigrum L. (SNL) has been traditionally
used as a herbal plant, whose fruit is believed to
have anti-tumor properties, although the mechanism
for the activity remains to be elucidated. An ethanol
extract from ripe fruits of SNL was prepared and
investigated the mechanism involved in its growth-
inhibitory effect on MCF-7 human breast cancer
cells. Results from proliferation assay using tritium
uptake showed that the proliferative capacity of
MCF-7 cells was strongly suppressed in the presence
of SNL ethanol extract. This was further confirmed
through MTT assay and trypan blue exclusion
experiments, which showed a very close correlation
between the SNL extract concentration and the
surviving cell numbers. The SNL extract-mediated
suppression of cell growth was verified to be
apoptotic, based on the appearance of DNA
laddering, increase in DNA fragmentation, and low
fluorescence intensity in nuclei after propidium
iodide staining of the cells. Furthermore, the SNL
extract was revealed to be a potential scavenger of
hydroxyl radicals and DPPH radicals rather than
superoxide anions. Collectively, findings suggest
that SNL fruit extract could be used as an anti-
oxidant and cancer chemo-preventive material.30
The DNA topoisomerase inhibitor β-lapachone is a
quinone obtained from the bark of the lapacho tree
(Tabebuia avellanedae) in South America. It has
been reported to possess a wide range of
pharmacological properties, and is a promising
cancer chemopreventive agent. The effects of β-
lapachone on the growth of the human hepatoma cell
line HepG2 were investigated. The results showed
that β-lapachone inhibits the viability of HepG2 by
inducing apoptosis, as evidenced by the formation of
apoptotic bodies and DNA fragmentation. Reverse
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1148
transcription-polymerase chain reaction and
immunoblotting results indicated that treatments of
cells with β-lapachone resulted in down-regulation
of anti-apoptotic Bcl-2 and Bcl-XL and up-regulation
of pro-apoptotic Bax expression. β-Lapachone-
induced apoptosis was associated with a proteolytic
activation of caspase-3 and -9 and degradation of
poly(ADP-ribose) polymerase protein. However, β-
lapachone treatment did not affect the inhibitor of
apoptosis proteins family and the Fas/FasL system.
Taken together, our study indicated that β-lapachone
may have potential as a chemopreventive agent for
liver cancer.31
The taxane diterpenoid from Taxol was first reported
in 1971, but it has only recently been recognized as a
highly effective anticancer drug. The history of
taxol's development is reviewed with an emphasis on
the problems that almost prevented the discovery of
its clinical activity, and on the key factors that kept it
under investigation. Recent research on the
structure-activity relationships and the synthesis of
taxol is also reviewed.32
In the determination the antioxidant and anti cancer
effects of Essiac, a tea prepared from a mixture of
four herbs Arctium lappa, Rumex acetosella, Ulmus
rubra and Rheum officinale, found that Essiac
inhibited hydroxyl radical-induced lipid
peroxidation by up to 50% at the 50% tea
preparation concentration. These data indicate that
Essiac tea possesses potent antioxidant and DNA-
protective activity, properties that are common to
natural anti-cancer agents. This study may help to
explain the mechanisms behind the reported anti-
cancer effects of Essiac.33
The activity of Uncaria tomentosa preparations on
cancer cells was studied using in vitro and in vivo
models. IC (50) values were calculated for
preparations with different quantitative and
qualitative oxindole alkaloid composition: B/W(37)
--bark extracted in water at 37 °C, B/W(b)--bark
extracted in boiling water, B/50E(37) --bark
extracted in 50% ethanol at 37 °C, B/E(b)--bark
extracted in boiling 96% ethanol, B/96E(37) --bark
extracted in 96% ethanol at 37 °C and B/SRT--bark
extracted in water and dichloromethane. Generally,
the results obtained showed a high correlation
between the total oxindole alkaloid content (from
0.43% to 50.40% d.m.) and the antiproliferative
activity of the preparations (IC(50) from >1000
μg/ml to 23.57 μg/ml). B/96E(37) and B/SRT were
the most cytotoxic preparations, whereas the lowest
toxicity was observed for B/W(37). B/96E(37) were
shown to be active against Lewis lung carcinoma
(LL/2) [IC(50) =25.06 μg/ml], cervical carcinoma
(KB) [IC(50) =35.69 μg/ml] and colon
adenocarcinoma (SW707) [IC(50) =49.06 μg/ml].
B/SRT was especially effective in inhibiting
proliferation of cervical carcinoma (KB) [IC(50)
=23.57 μg/ml], breast carcinoma (MCF-7) [IC(50)
=29.86 μg/ml] and lung carcinoma (A-549) [IC(50)
=40.03 μg/ml]. Further animal studies on mice
bearing Lewis lung carcinoma showed significant
inhibition of tumor growth by B/W(37) administered
for 21 days at daily doses of 5 and 0.5 mg
(p=0.0009). There were no significant changes in the
cell cycles of tumor cells with the exception of cell
decrease at the G2/M phase after the administration
of B/96E(37) at a daily dose of 0.5 mg and the
G(1)/G(0) cells cycle arrest demonstrated after the
B/SRT therapy at a daily-dose of 0.05 mg. All tested
preparations were non-toxic and well tolerated.34
Cycloviolacin O2 (CyO2), a cyclotide from Viola
odorata (Violaceae) has antitumor effects and
causes cell death by membrane permeabilization. In
the breast cancer line, MCF-7 and its drug resistant
subline MCF-7/ADR, the cytotoxic effects of CyO2
(0.2-10 microM) were monitored in the presence and
absence of doxorubicin (0.1-5 microM) using cell
proliferation assays to establish its chemosensitizing
abilities. SYTOX Green assays were Sperformed to
verify membrane permeabilization and showed
cellular disruption correlates with cyclotide
chemosensitization. Fluorescence microscopy
studies demonstrated increased cellular
internalization of doxorubicin in drug resistant cells
when coexposed to CyO2. Interestingly, CyO2 did
not produce significant membrane disruption in
primary human brain endothelial cells, which
suggested cyclotide specificity toward induced pore
formation in highly proliferating tumor cells.
Furthermore, three novel cyclotides (psyle A, C and
E) from Psychotria leptothyrsa (Rubiaceae) were
also monitored for cytotoxic activity. The cyclotides
displayed potent cytotoxicity (IC50 = 0.64->10
microM), and coexposure to cyclotides significantly
enhanced doxorubicin induced toxicity (IC50 =
0.39-0.76 microM). This study documents several
cyclotides with robust cytotoxicity that may be
promising chemosensitizing agents against drug
resistant breast cancer.35
Viscum album agglutinin-1 (VAA-1) from where it
is found is assumed to be the biologically most
active ingredient of mistletoe extracts that are often
used as adjuvant cancer therapy. To develop new
approaches for lung cancer treatment, the
antinewplastic activity of the evaluated the
antineoplastic activity of VAA-1 was evaluated in
combination with other chemotherapeutic drugs,
including doxorubicin, cisplatin and taxol in the
human lung carcinoma cell line A549.36
Detailed methods for in vitro/in vivo evaluation of
anticancer drugs, with special reference to mistletoe
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1149
extracts from plant Viscum Album, have been
reviewed. Mistletoe extracts have been shown to
possess significant antitumor activity, in vivo,
against murine tumors, Lewis lung carcinoma, colon
adenocarcinoma 38 and C3H mammary
adenocarcinoma 16/C. Methods for the extraction of
biologically active alkaloids from mistletoe and their
anticancer activities are presented. The possible
origin of alkaloids in mistletoe plants, and their
contributions towards a mechanism of anticancer
activities of mistletoe extracts, were proposed.37
Proanthocyanidins (PAs), also known as condensed
tannins, are naturally occurring oligomers and
polymers of flavan-3-ol monomer units widely
found in the leaves, flowers, fruits, seeds, nuts and
barks of many plants. Grape seed (Vitis vinifera L.)
proanthocyanidins (GSPs) which have been used as
nutritional supplements and , as antioxidants, which
prevents in preventing atherosclerosis and
cardiovascular diseases. The anthracycline antibiotic
adriamycin (Doxorubicin, DXR) is a cancer
chemotherapeutic agent that interferes with the
topoisomerase II enzyme and generates free radicals.
In the present study, GSPs (1.680, 3.375, or 6.750
mg/mL) alone were examined for genotoxicity, and
combined with DXR (0.125 mg/mL) for
antigenotoxicity, using the standard (ST) and high
bioactivation (HB) versions of the wing somatic
mutation and recombination test in Drosophila
melanogaster. The results observed in both crosses
were rather similar. GSPs themselves did not show
genotoxicity at the doses used but they suppres the
DNA damage induced by DXR in a dose-dependent
manner. Comparison of the frequencies of wing
spots in the marker-heterozygous (MH) flies and
balancer-heterozygous (BH) flies from both crosses,
indicated that induced recombination was the major
response for the treatments with DXR alone. The co-
treatments demonstrated that GSPs have some anti-
mutagenic activity; however, anti-recombinagenic
activity was the major-response.38
Vitis Vinifera :- Investigations were carried out for
evalution of antitumor and antioxidant activity of
Ethanolic extract of vitis vinifera L.Leaves. For its
antitumor, antioxidant activity in Ehrlich ascites
carcinoma (EAC) induced swiss albino mice. The
antitumor effect and antioxidant role was assessed
using tumor volume, packed cell volume and
estimation of liver LPO and antioxidant enzymes
such as SOD, CAT. The Ethanolic extract
administered at 200 and 400 mg/kg b.w.per day for
14 days, after 24 hours of tumor inoculation.
Treatment with extract at a dose of 200 and 400
mg/kg increased mean survival time. Treatment with
extract also decreased the levels of LPO and
increased the levels of superoxide dismutase,
catalase. The results suggest that ethanolic extract of
vitis vinifera possess significant antitumor,
antioxidant effects in EAC tumor bearing mice.39
Zingiber officinale:- Ginger may act as an anti-
cancer and anti-inflammatory agent by inactivating
NFkappaB through the suppression of the pro-
inflammatory TNF-alpha.40
Some Anticancer Natural Products: 41
Name
Biological source
Geographical
source
Chemical
constituent
Aconite
Dried root of
aconitum napellus,
Ranunculacece
Hungary, germany,
spain Switzerland
Aconitine,
hypaconitine,
neopelline, napelline,
neoline
Allium Sativum
(Garlic)
Bulb of the plant
know as allium
sativum, lilaceae
Central asia,
southern Europe,
USA and India
Carbohydrate,
protein (albumin),
fat, mucilage
Artemisia
Unexpanded flower
heads of Artemisia
cina, Artemisia
buvifolia wall,
Artemisia maritime,
compositae
Pakistan, turkey,
from Kashmir to
kumaon in
Himalayas
Essential oil,
santonin, artemisin
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1150
Name
Biological
source
Geographical
source
Chemical
constituent
Uses
Camellia
sinensis
Prepared leaves
and leaf buds of
Thea sinensis,
Theaceae
India, Shri
lanka., china,
Indonesia,
japan
Caffeine,
theobromine,
theophylline,
gallatonic acid
CNS stimulant, diuretic
Comptotheca
accuminata
Dried stem wood
of comptotheca
acuminate,
nyssaceae
China, Tibet,
southern china
Quinoline alkaloid,
camtothecin, 10
hydroxy
camptothecin, 10
methoxy
camptothecin
DNA topoisomerase
Iinhibitors, antitumour,
antileukemia
Catharanthus
roseus
Dried whole plant
of catharanthus
roseus,
apocunaceae
South africa,
india, USA,
Europe,
australia
Vincristine,
vinblastine,
ajmalicine
Antineoplastic, acute
leukemia, hodgkin’s
disease
Curcuma longa
Dried as well as
fresh rhizome of
the plant known
as curcuma
longa,
zingiberaceae
Tamil Nadu,
Andhra
Pradesh, kerala
Curcuminoids,
curcumin, volatile
oil, starch
Anti inflammatory, anti
arthritic, cervical
cancer
Glycyrrhiza
glabra
Dried peeled or
unpeeled root and
stolon of
glycyrrhiza
glabra,
leguminosae
Spain, sicily,
England
Glycurrhizin,
glycyrrhizinic acid
which on hydrolysis
yield glycyrrhetinic
acid
Expectorant,
demulcent, antigastric
effect
Panax ginseng
Dried root of
panax ginseng,
Araliaceae
Korea, china,
Russia, Canada,
USA
Ginsenoisides,
panaxosides,
chikusetsusaponin
Immunomodulatory
drugs
Podophyllum
peltatum
Dries rhizomes
and root of
podophyllum
peltatum,
barberidaceae
From Kashmir
to Sikkim and
parts of U.P
Podophyllin,
podophyllotoxin,
alpha and beta
peltatins
Cytotoxic action,
treatment of veneral,
purgative
Taxus
brevifolia
Dried leaves,
bark and root of
various species of
taxus, taxaceae
India, Canada,
America
Taxane,
cephalomannine, 10-
deacetyl baccatin,
taxol
Lung carcinoma,
gastric and cervical
cancers and also
carcinomas of head,
neck, prostate and
colon
Viola odorata
Dried aerial parts
obtained from
viola odorata,
violaceae
India (Kashmir,
himachal
Pradesh,
kumaon hills)
Essential oil,
alkaloid, saponins,
glycoside of methyl
salicylate.
Expectorant,
diaphoretic, antipyretic,
antibacterial
Zingiber
Rhizomes of
zingiber
officinale roscoe,
zingiberaceae
South asia,
Africa,
Australia,
Mauritius,
jamaica,
Taiwan, india.
Volatile oil, starch,
fat, fibre, inorganic
material, residual
moisture, acrid
resinous matter.
Stomachic, aromatic,
carminative, stimulant,
flavouring agent.
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1151
Conclusion:
Medicinal plants have contributed a rich health to
human beings. Plant extracts and their bioactive
compounds present in them which are responsible
for anticancer activity have to be screened for their
valuable information. This review had given some of
the plants possessing anticancer activity for various
types of cancer. This review can help others to
explore herbs to further extent and its use in various
other disease and toxicity studies along with clinical
trials.
References:
1. Lemkebthomas L., Williams D. A., Roche V. F.,
William Z. S., Foye’s principles of medicinal
chemistry., 6th edition, 2008, 1147-1148
2. Z., Michael S., Eran Ben-A., and Bashar S.,
Greco-Arab and Islamic Herbal-Derived
Anticancer Modalities: From Tradition to
Molecular Mechanisms, Evidence-Based
complementary and Alternative Medicine.,
2012,13
3. Wen T., Jinjian L., Mingqing H., Yingbo Li.,
Meiwan C., Guosheng W., Jian G., Zhangfeng
Z., Zengtao X., Yuanye D., Jiajie G., Xiuping
C., and Yitao W., Anti-cancer natural products
isolated from chinese medicinal herbs, Chin
Med., 2011, 6, 27 .
4. Prema R., Sekar S.D., Chandra Sekhar K B.,
Review On: Herbs As Anticancer Agents, Int. J.
Pharma & Ind. Res., 2011, 1, 105.
5. Pandey G and Madhuri S., Some medicinal
plants as natural anticancer agents, Phcog Rev.,
2009, 3, 259-263.
6. Dholwani K.K., Saluja A.K., Gupta A.R., and
D.R. Shah., A review on plant-derived natural
products and their analogs with anti-tumor
activity, Indian J Pharmacol., 2008, 40, 4958.
7. Svoboda G. H., Poore G. A., Simpson P. J and
Boder G. B., Alkaloids of Acronychia Baueri
Schott I: Isolation of the alkaloids and a study of
the antitumor and other biological properties of
acronycine, Journal of Pharmaceutical Sciences.,
1996, 55, 758768.
8. Ariga T., and Seki T., Antithrombotic and
anticancer effects of garlic-derived sulfur
compounds: A review, BioFactors., 2006, 26,
93103.
9. Thomson M and Ali M., Garlic [Allium
sativum]: a review of its potential use as an anti-
cancer agent, Curr Cancer Drug Targets., 2003,
3, 67-81.
10. Jung M.J., Yin Y., Heo S.I., Wang M.H.,
Antioxidant and Anticancer Activities of Extract
from Artemisia capillaries, Korean Journal of
Pharmacognosy., 2008, 39, 194-198.
11. William C.S and Kwok N. L., In vitro and in
vivo anti-tumor effects of Astragalus
membranaceus, Cancer Letters., 2007, 252, 43
54.
12. Kapadia G.J., Tokuda H., Konoshima T.,
Nishino H., Chemoprevention of lung and skin
cancer by Beta vulgaris (beet) root extract,
Cancer Lett., 1996, 100, 211-214.
13. Valcic S., Timmermann B.N., Alberts D.S.,
Wachter G.A., Krutzsch M., Wymer J., Guillén
JM., Inhibitory effect of six green tea catechins
and caffeine on the growth of four selected
human tumor cell lines, Anticancer Drugs.,
1996, 7, 461-8.
14. Lorence.A.F., Bolivar M., Nessler C.L.,
Camptothecin and 10-hydroxycamptothecin
from Camptotheca acuminata hairy roots,
Physiology and Biochemistry Plant Cell
Reports., 22, 6, 437-441.
15. Maria Manuela R. Costa., Frederique Hilliou.,
Patrícia Duarte., Luís Gustavo Pereira., Iolanda
Almeida., Mark Leech., Johan Memelink.,
Alfonso Ros Barceló., Mariana Sottomayor.,
Molecular Cloning and Characterization of a
Vacuolar Class III Peroxidase Involved in the
Metabolism of Anticancer Alkaloids in
Catharanthus roseus.,Plant Physiology., 2008,
146, 403-417.
16. Mi Ja Chung., Cha-Kwon Chung., Yoonhwa
Jeong., Seung-Shi Ham., Anticancer activity of
subfractions containing pure compounds of
Chaga mushroom (Inonotus obliquus) extract in
human cancer cells and in Balbc/c mice bearing
Sarcoma-180 cells, Nutr Res Pract., 2010, 4,
177182.
17. Kuttan R., Bhanumathy P., Nirmala K., George
MC., Potential anticancer activity of turmeric
(Curcuma longa), Cancer Lett., 1985, 29, 197-
202.
18. Lakshmi S., Padmaja G and Remani P.,
Antitumour Effects of Isocurcumenol Isolated
from Curcuma zedoaria Rhizomes on Human
and Murine Cancer Cells, International Journal
of Medicinal Chemistry., 2011, 13.
19. JING Jing., YANG Ruolin., LU Yang., The
Anticancer Activity of Compounds in Lipophilic
Fraction of Daucus carota, Journal of Guiyang
Medical College., 2008, 05, 014.
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1152
20. Yue Fu., Tze-chen Hsieh., Junqiao Guo., Jan
Kunicki., Marietta Y.W.T., LeeZbigniew
Darzynkiewicz., Joseph M. Wu., Licochalcone-
A: A novel flavonoid isolated from licorice root
(Glycyrrhiza glabra), causes G2 and late-G1
arrests in androgen-independent PC-3 prostate
cancer cells, Biochemical and Biophysical
Research Communications., 2004, 322, 263
270.
21. Karmakar SR., Biswas SJ., Khuda-Bukhsh AR.,
Anti-carcinogenic potentials of a plant extract
(Hydrastis canadensis): I. Evidence from in vivo
studies in mice (Mus musculus), Asian Pac J
Cancer Prev., 2010, 11, 545-51.
22. C. Anesini., A. Genaro., G. Cremaschi., J.
Boccio., M. Zubillaga., L. Sterin Borda., E.
Borda., In vivo” antitumor activity of Larrea
divaricata C.: comparison of two routes of
administration, Phytomedicine., 2011, 5,41-45.
23. Wan Chik., Wan Dalila., Amid Azura., Jamal
Parveen., Purification and Cytotoxicity Assay of
TOmato (Lycopersicum esculentum) Leaves
Methanol Extract as Potential Anticancer Agen.,
Journal of Applied Sciences, 2010, 10, 3283-
3288.
24. Kang JH., Song KH., Woo JK., Park MH., Rhee
MH., Choi C., Oh SH., Ginsenoside Rp1 from
Panax ginseng exhibits anti-cancer activity by
down-regulation of the IGF-1R/Akt pathway in
breast cancer cells, Plant Foods Hum Nutr.,
2011, 66, 298-305.
25. Nagamine MK., da Silva TC., Matsuzaki P.,
Pinello KC., Cogliati B., Pizzo CR., Akisue G.,
Haraguchi M., Górniak SL., Sinhorini IL., Rao
KV., Barbuto JA., Dagli ML., Cytotoxic effects
of butanolic extract from Pfaffia paniculata
(Brazilian ginseng) on cultured human breast
cancer cell line MCF-7, Exp Toxicol Pathol.,
2009, 61, 75-82.
26. Beth Shultz., Wilkes University., Wilkes-Barre
P.A., Medical Attributes of Podophyllum
peltatum Mayapple., 2001, 408-4758.
27. Choi SG., Kim J., Sung ND., Son KH., Cheon
HG., Kim KR., Kwon BM., Anthraquinones,
Cdc25B phosphatase inhibitors, isolated from
the roots of Polygonum multiflorum Thunb, Nat
Prod Res., 2007, 21, 487-93.
28. Lin JY., Liu SY., Studies on the antitumor
lectins isolated from the seeds of Ricinus
communis (castor bean), Toxicon., 1986, 24,
757-65.
29. Jeong JB., Jeong HJ., Park JH., Lee SH., Lee
JR., Lee HK., Chung GY., Choi JD., de Lumen
BO., Cancer-preventive peptide lunasin from
Solanum nigrum L. inhibits acetylation of core
histones H3 and H4 and phosphorylation of
retinoblastoma protein (Rb), J Agric Food
Chem., 2007, 55, 10707-13.
30. Y.-O Son., J Kim., J.-C Lim., Y Chung., G.-H
Chung., J.-C Lee., Ripe fruits of Solanum
nigrum L. inhibits cell growth and induces
apoptosis in MCF-7 cells, Food Chem Toxicol.,
2003, 41, 14211428.
31. Hyun Joo Woo., Kun-Young Park., Chung-Ho
Rhu., Won Ho Lee., Byung Tae Choi., Gi
Young Kim., Yeong-Min Park., Yung Hyun
Choi., β-Lapachone, a Quinone Isolated from
Tabebuia avellanedae, Induces Apoptosis in
HepG2 Hepatoma Cell Line Through Induction
of Bax and Activation of Caspase, Journal of
Medicinal Food., 2006, 9, 161-168.
32. Kingston David G. I., Taxol, an Exciting
Anticancer Drug from Taxus brevifolia, Human
Medicinal Agents from Plants., 1993, 534, 138
148.
33. Kylenorton , The World Most Popular Herbs
Slippery elm (Ulmus rubra) Health Benefits and
Side Effects, Health article.,Posted on January
27, 2012
34. Pilarski R., Filip B., Wietrzyk J., Kuraś M.,
Gulewicz K., Anticancer activity of the Uncaria
tomentosa (Willd.) DC. preparations with
different oxindole alkaloid composition,
Phytomedicine., 2010, 17, 1133-9.
35. Gerlach SL., Rathinakumar R., Chakravarty G.,
Göransson U., Wimley WC., Darwin SP.,
Mondal D., Anticancer and chemosensitizing
abilities of cycloviolacin 02 from Viola odorata
and psyle cyclotides from Psychotria
leptothyrsa, Biopolymers., 2010, 94, 617-25.
36. Siegle I., Fritz P., McClellan M., Gutzeit S.,
Mürdter TE., Combined cytotoxic action of
Viscum album agglutinin-1 and anticancer
agents against human A549 lung cancer cells,
Anticancer Res., 2001, 21, 2687-91.
37. Khwaja TA., Dias CB., Pentecost S., Recent
studies on the anticancer activities of mistletoe
(Viscum album) and its alkaloids, Oncology.,
1986, 43, 42-50.
38. De Rezende AA., Graf U., Guterres Zda R., Kerr
WE., Spanó MA., Protective effects of
proanthocyanidins of grape (Vitis vinifera L.)
seeds on DNA damage induced by Doxorubicin
in somatic cells of Drosophila melanogaster,
Food Chem Toxicol., 2009, 47, 1466-72.
39. Mahadik Vaishali J., Patil Piyusha B., Patil
Sandip B., Naikwade Nilofar S., Evaluation of
antitumor and antioxidant activity of vitis
vinifera l. against ehrlich ascites carcinoma
induced mice, international journal of
pharmaceutical research and development.,
2011, 3, 10.
Nidhi Agarwal et al /Int.J.PharmTech Res.2012,4(3)
1153
40. Habib SH., Makpol S., Abdul Hamid NA., Das
S., Ngah WZ., Yusof YA., Ginger extract
(Zingiber officinale) has anti-cancer and anti-
inflammatory effects on ethionine-induced
hepatoma rats, Clinics (Sao Paulo)., 2008, 63,
807-13.
41. Kokate C.K., purohit A.P., Gokhale SB., nirali
prakashan., 39th edition., 2007, 215,
221,349,385, 395, 360, 381, 415, 424, 450, 484,
511, 515, 534.
*****
... Most of these anticancer methods and medicines lead to acute consequences for the patient and might have toxic effects on healthy tissues [12]. Medicinal herbs, as a rich resource of antioxidants, have been surveyed to produce herbal anticancer medicines and investigate anticancer characteristics of which [13][14][15][16][17][18][19]. According to the world health organization, medicinal herbs would be the best resource for obtaining various medicines. ...
... The results obtained from FT-IR, 1 HNMR, and 13 CNMR spectra revealed that an imine bond was obtained via a condensation reaction between the carbonyl group of curcumin with NH2 group of amine. This might be due to the tautomeric structures of curcumin. ...
... The FT-IR, 13 CNMR, and 1 HNMR spectroscopy methods were used to determine the exact structure of the products. I n the FT-IR spectra for both molar ratios, the peaks above 3300 cm-1 are related to the tensile vibrations of the enoleic and phenolic OHs, respectively. ...
Article
Full-text available
Medicinal herbs have been taken into consideration for cancer treatment because of the high prevalence of cancer and the severe consequences of chemotherapy. Turmeric, the common name of the Curcuma longa plant, is one of these herbs as Indian spices being applicable for food spices as well as treatment of various diseases. The medicinal and biological effects of turmeric are actually associated with the main component of its rhizome, i.e. curcumin. Curcumin has antioxidant, antibacterial, anticancer, antifungal, and antiviral properties. In this research, curcumin derivatives were synthesized via a condensation reaction of some aromatic amines (aniline, 2-nitroaniline, 4-ethyl aniline) with curcumin. The effects of the molar ratio of amine: to curcumin on the type of products were also examined. The structure of the products was characterized by FT-IR, 1HNMR, and 13CNMR spectroscopy. The anticancer activities of compounds were investigated by the MTT assay (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliu bromide test). It was evaluated with different dosages of curcumin derivatives at different times against BRC-9 breast cancer cells which exhibited the most potent anticancer activity.
... The mechanisms of natural components are diversifiedincluding public healthcare promotion, cancer prevention, and anti-proliferative, and compound repurposes. Herbal medicine has rich components of anticancer activities of great therapeutic importance (prevention, treatment, and reversals) [79][80][81][82][83][84][85][86][87][88][89]. More chemical knowledge or technical advances should be integrated into all these processes. ...
... Herbal prescription is associated with treatment outcomes. It needs in-depth medical knowledge and expertise [85][86][87]. Different drugs should be well combined and dosed. In one prescription, drugs are divided into four levels and domains-king, court, assistant, and soldiers. ...
Article
Anticancer drug development is becoming complex and demanding because human cancer leads to 12% of global human mortality. Chemical and pharmacological breakthroughs play leading roles in updating drug evaluation and development for different types of tumors. Chemical and pharmacological breakthroughs manifest in different facets. A large proportion of financial and workload increases in drug discovery must be paid off. In front of complexity, difficulties, and financial increase of drug development, evaluative promotion must go miniature- wise and single-cell-wise. Multi-omics knowledge and technology are greatly expanded and understood in depth. This type of technical trend is suitable for current experimental exploration and clinical occasions. Technical and pharmacologic advances are especially emphasized to address this trend. Presently, the anticancer pharmaceutical study is multi-faceted and risk-taking. To keep up this momentum, multi-disciplinary drug evaluation, clinical selection, and combination principles should be discovered. Past and futuristic chemical and pharmacological interactions and breakthroughs are discussed. In summary, the landscape of pharmaceutical investigation should be integrated with chemical and pharmacological knowledge in every facet of drug development and clinical personalization.
... The "herbs" that cancer patients and survivors utilize are the main topic of this article. These goods come from plants and are utilized as food, spices, nutritional supplements, and traditional medicine [6,[23][24][25][26][27][28][29][30][31][32][33]. ...
Article
Numerous phytochemical substances found in food and their artificial derivatives have recently been suggested as cancer treatments. Unfortunately, there is a dearth of information regarding compounds produced from non-edible plants, while the data accessible in relevant literature focuses on the anti-cancer activities of compounds derived from edible plants. Therefore, it is still unclear what mechanisms underlie their anti-cancer actions. The existing information on the anti-cancer properties of six phytochemical-derived compounds—rottlerin, berbamine, sparstolonin B, sulforaphane, plumbagin, and 6-shogaol—derived from both edible and non-edible plants is compiled in this review. These substances serve as bioactive indicators of tumor cytotoxicity. Therefore, knowing how they work will give the justification for using these substances in combination with other medications to fight cancer. Thus, we have summarized the works as a review to present the therapeutic application of herbal drugs for cancer therapeutics.
... Facing with this dilemma, blood circulatory tumors or their biomarkers are new hopes for therapeutic selection and successes [26][27][28]. They can be determined for herbal medicines or other types of clinical cancer treatment [29][30][31]. This diagnostic new trend is useful for further treatment updating. ...
Article
Full-text available
Cancer bone metastasis was common features for cancer patients. It is very painful for patients and therapeutic resistance in the clinic. Drug treatment needs to improve for both growth inhibition and symptom management. To promote therapeutic paradigms, clinical drug treatment should be personalized by different platforms and paradigms. This editorial discusses bone cancer metastasis treatment in personalized medicine
... The chief constituents of the oil are di allyl di sulphide (60%), dially tri sulphide (20%), ally propyl disulphie (6%), a small quantity of diethyl di-sulphide and probably di ally poly sulphide. and it is also contain some amount of ajoene, allicin, allin, allixinetc [13,14]. Allivum sativum inhibits the genesis and as well as growth of the cancer by enhancing activity of the ISSN: 2250-1177 ...
Article
Full-text available
The present study aim to get novel approach of herbal chitosan nanoparticle to get improved efficacy of the drug with a less side effect. The present study include formulation and evaluation of chitosan loaded nanoparticle of Allivum sativum by using ionic gelation method. In present study five different formulations were prepared by using the different ratio of polymer and TPP. The prepared nanoparticle was evaluated for its particle size, zeta potential, scanning electron microscopy (SEM), production yield, encapsulation efficiency (EE), stability and in-vitro drug release. The optimized Allivum sativum extract loaded chitosan nanoparticle was found with production yield of 73.59%. They were found round shape and with smooth surface. The in-vitro release profile sustained up to 90.65 %. Thus results have found F1 formulation was more stable. It showed highest in-vitro drug release. So it was found that F1 was best formulation among the all batches prepared. This formulation can be further use to treat disease like cancer. Keywords: Chitosan nanoparticle, SEM, Allivum sativum, Anti-cancer activity, Chemotherapy
... Plants have traditionally been employed to cure a number of ailments, including cancer. As a result of such ongoing research, many secondary plant metabolites, including vincristine, vinblastine, paclitaxel, docetaxel, etoposide, taniposide, camptothecin and irinotecan are functioning as anticancer drugs (Agarwal et al., 2012). Well-stored plant kingdoms in Bangladesh can help in ethnopharmacological research on plants, which may offer helpful tips for finding new cancer medicines. ...
Article
Full-text available
Antioxidants and cancer are somewhat related to each other. The study was designated to evaluate the antioxidant activities of the aerial parts of Pyrosia lanceolata (P. lanceilata, Fam. Polypodiaceae) and their cytotoxic potential in a lung cancer cell line (A549). The extraction of plant material was performed by using methanol (CME), followed by solvent-solvent partitioning with different solvents. The methanol (CME) and its subsequent fractions (pet-ether PEF, chloroform CHF, ethyl acetate EAF and aqueous AQF fractions) confirmed the presence of alkaloids, flavonoids, phenols, tannins and terpenoids at different degrees. The phenolic and flavonoid content were found to be 69.46, 37.93, 64.61, 126.74 and 60.64 mg of GAE/gm and 33.93, 4.11, 45.68, 146.95, and 44.36 mg of CAE/gm of dried CME, PEF, CHF, EAF and AQF, respectively. The overall antioxidant and iron reduction capacities of CME and all the fractions were in the following order: EAF > CHF > CME > AQF > PEF and EAF > CHF > CME > AQF > PEF, respectively. Among the fractions, EAF significantly scavenged DPPH (IC50 of 1.34 μg/ml) and OH radicals (IC50 of 4.38 μg/ml), which closely resembled those of standard BHT (IC50 of 0.9 μg/ml) and CA (IC50 of 2.73 μg/ml), respectively. Moreover, EAF (IC50 of 14.06 μg/ml) demonstrated a similar effect on inhibiting lipid peroxidation when compared to standard CA (IC50 of 13.86 μg/ml). In addition, CHF (24.25%) and EAF (14.9%) showed a potent cytotoxic effect in A549 cells. Our results suggest that P. lanceolata might be a good source of anticancer potential having antioxidant activity. Bangladesh Pharmaceutical Journal 27(2): 137-148, 2024 (July)
... The adverse effects effects observed with conventional chemotherapy and the emergence of drug resistance highlight the critical role of exploring natural compounds as potential therapeutic agents in combating cancer. Several publications show that natural substances exhibit strong in vitro and in vivo anticancer potentials (Hashem et al., 2022;Zhong et al., 2021;Agarwal et al., 2012). In this investigation, we found that the saponin extract of A. rosea seeds exhibited anticancer activity against cancer cell lines. ...
Article
Background: Natural compounds are essential targets in anticancer research due to the toxic effects of current chemotherapy and drug resistance. Methods: Saponin extraction from Alcea rosea L. was carried out using 20% methanol and liquid-liquid extraction coupled with the Solid phase extraction (SPE) approach. The saponin fraction was explored for its cytotoxic activity against Huh-7 and MDA-MB-231 cancer cell lines and a non–cancer cell line (HUVEC). The cytotoxic activity and oxidative stress were assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and 2,7 dichlorofluorescein diacetate dyes respectively. The apoptotic potential was investigated using DAPI and acridine orange-ethidium bromide dual staining. Result: The saponin fraction exhibited cytotoxic potential against the cell lines investigated. The IC50 values of the saponin fraction were 49.02, 300 and 325 µg\mL against Huh-7, MDA-MB-231 and HUVEC cell lines, respectively. The cytotoxicity for the extract was dose-dependent. The saponin fraction calculated selectivity index (SI) value indicated high selectivity towards Huh-7 cells (SI = 6.62) compared with normal HUVEC cells. Huh-7 cells treated with saponin fraction showed cellular and nuclear morphological changes, such as apoptotic body formation and chromatin condensation, as observed using light and fluorescent microscopy. However, further investigation is required to assess the the saponin fraction as a potential therapeutic agent.
... Anticancer drugs Drugs to reduce the toxicity of anticancer drugs [16] Cytotoxic drugs or radiotherapies High selective biotherapies [17][18][19][20] Cytotoxic drugs Targeted agents [21] Cytotoxic drugs or radiotherapies Less toxic assistant or adjuvant agents [22][23][24] Cytotoxic drugs Drug-resistant approve agents [25] Western medicine Traditional Chinese medicine [26][27][28] Drugs targeting primary tumor Antimetastatic agents [29][30] Anticancer drugs Cancer or virus vaccines [31] ...
Article
Advanced stage of cancer patient therapies is unsatisfactory and high-mortality of the disease now. A growing consensus for late-stage cancer patient treatment calls for excellent drug combination in clinical trials. Some progress in this respect has been made worldwide.Despite growing popularity in clinical applications, the anticancer drug combinational rules remain to be discovered and massively applied according to clinical situations and personalized status of cancer patients. In the past decade, we have focused on this matter with watchful eyes and scientific imaginations. TTis article reiterates these types of cancer managements by providing more matured standards and personalized systems. Future landscapes and insights into cancer drug combinational studies and applications are addressed. In order to update this promising clinical paradigm, some key avenues of therapeutic promotion for anticancer drug combination are highlighted in this article. Experimental or clinical pathways and techniques to update cancer treatment will be carried out in the clinic. A variety of clinical drug selection systems in the future are challenged.
Chapter
Cancer is a heterogeneous disease with a range of symptoms and forms. Usually, cancer begins with a single cell that experiences genetic mutations or alterations that disrupt the cell’s normal regulatory processes. Conventional chemotherapy is the most widely used option for cancer treatment, but the cytotoxic effects of synthetic drugs affecting both cancerous and normal rapidly dividing cells, leading to systemic side effects. Unlike conventional chemotherapy, targeted delivery limits the therapeutic agent’s exposure to healthy tissues, thereby reducing side effects. These treatments are aimed to interfere with certain molecules that are involved in development, growth, and survival of cancer cells. Therefore, nano-phytochemicals-based drug delivery systems offer various benefits including enhance targeted delivery, increased therapeutic efficacy, reduced side effects, and improved patient compliance. Adding phytochemicals as a bioactive substance into these systems expands their potential even more. Phytochemicals are naturally occurring substances that present in plants, have been investigated for possible anticancer effects. Phytochemicals have a variety of biological activities, such as anti-inflammatory, anticancer, and antioxidant properties. Some of the known phytochemicals found in plants include curcumin, resveratrol, epigallocatechin gallate, quercetin, lycopene, genistein, berberine, etc. Targeted delivery reduces side effects by limiting the therapeutic agent’s exposure to healthy tissues. The ability to release phytochemicals in a controlled and sustained manner is one of the main benefits of utilizing nanotechnology in drug delivery systems. To protect the phytochemicals from degradation, improving their solubility, and facilitating controlled and targeted release, these compounds are encapsulated within nanosized carriers such as liposomes, micelles, or nanoparticles. The properties of the nanocarriers can be modified to alter the release rate. This chapter aims to provide an overview of the nano-phytochemical-based drug delivery system for cancer treatment.
Article
Full-text available
At present Cancer and Tumor is a common disease and very badly affected to a large number of world population masses. Various modern medical, scientific research and treatment are available to treat Human cancer and tumor now a days. Some of them are very useful and some show many toxic, hazardous and harmful effects upon treated Human cells. At present natural occurring resources substances like herbal, medicinal plant based drugs are trending, discovered of very effected novel drug development bioactive marker compounds for the treatment of various type of illness and diseases. These are non-toxic and give us maximum efficacy and safety. In this review paper, we can studies of Pharmacological, bioactive phytochemical constituents, therapeutic uses, medicinal potent values of herbal Anti-Cancerous, Anti-Tumour’s, Anti-Carcinogenic and Anti-Cytotoxic 32 species single medicinal plants which are remains a significant challenging task on global levels, explored and available in Asian and southern, northern Himalayan region on the basis of Google search engine databases. These are some 32 species herbal medicinal plants used to treat and cure of various therapeutic illness of public mankind from since ancient time. This review study aims to evaluate, numerous remarkable potent anticancerou’s, antitumor’s, anticarnogenic activities commonly both In-vitro and In-vivo, due to the presence of Alkaloids, flavonoids, steroidal, glycosides, terpenoids, tannin, phenolic, saponins, lignin’s, proteins and phenolic acids, Anti-cancer’s and Anti-tumor’s major bioactive compounds. However, more research is needed to explore the In-vivo clinical evaluation for their future’s uses, application in treating various ailments for beneficial to public, mankind. Keywords: Anticancer’s, Antitumor’s, Anti-Carcinogenic agent, bioactive phytochemical constituents, Pharmacological, and therapeutic medicinal potential values, electronic Google search engine databases. Keywords: Cancer, Anti- Carcinogenic agents, Herbal Medicinal Plants, Antitumor.
Article
Full-text available
India is the largest producer of medicinal plants and is rightly called the "Botanical garden of the World". The medicinal plants, besides having natural therapeutic values against various diseases, also provide high quality of food and raw materials for livelihood. Considerable works have been done on these plants to treat cancer, and some plant products have been marketed as anticancer drugs, based on the traditional uses and scientific reports. These plants may promote host resistance against infection by re-stabilizing body equilibrium and conditioning the body tissues. Several reports describe that the anticancer activity of medicinal plants is due to the presence of antioxidants in them. In fact, the medicinal plants are easily available, cheaper and possess no toxicity as compared to the modern (allopathic) drugs. Hence, this review article contains 66 medicinal plants, which are the natural sources of anticancer agents.
Article
Full-text available
Curcuma zedoaria belonging to the family Zingiberaceae has been used in the traditional system of medicine in India and Southwest Asia in treating many human ailments and is found to possess many biological activities. The rationale of the present study was to isolate, identify, and characterize antitumour principles from the rhizomes of Curcuma zedoaria, to assess its cytotoxic effects on human and murine cancer cells, to determine its apoptosis inducing capacity in cancer cells, and to evaluate its tumour reducing properties in in vivo mice models. Isocurcumenol was characterized as the active compound by spectroscopy and was found to inhibit the proliferation of cancer cells without inducing significant toxicity to the normal cells. Fluorescent staining exhibited the morphological features of apoptosis in the compound-treated cancer cells. In vivo tumour reduction studies revealed that a dose of 35.7 mg/kg body weight significantly reduced the ascitic tumour in DLA-challenged mice and increased the lifespan with respect to untreated control mice.
Article
Full-text available
The incidence of cancer is increasing in the developed countries and even more so in developing countries parallel to the increase in life expectancy. In recent years, clinicians and researchers advocate the need to include supportive and palliative care since the establishment of the diagnosis and throughout the duration of treatment, with the goal of improving patients' quality of life. This patient-centered approach in supportive care is also shared by various traditional and complementary medicine approaches. Traditional Arab-Islamic medicine offers a variety of therapeutic modalities that include herbal, nutritional, and spiritual approaches. Physicians and scholars, such as Avicenna (980-1037), Rhazes (965-915), Al Zahrawi (936-1013), and Ibn al Nafis (1218-1288) referred to cancer etiology in various medicinal texts and suggested both preventive and therapeutic remedies to alleviate suffering. This review presents research data related to the anticancer activities of herbs used in Arab-Islamic medicine and allude to their potential role in improving the quality of life of cancer patients.
Article
Full-text available
In recent years, a number of natural products isolated from Chinese herbs have been found to inhibit proliferation, induce apoptosis, suppress angiogenesis, retard metastasis and enhance chemotherapy, exhibiting anti-cancer potential both in vitro and in vivo. This article summarizes recent advances in in vitro and in vivo research on the anti-cancer effects and related mechanisms of some promising natural products. These natural products are also reviewed for their therapeutic potentials, including flavonoids (gambogic acid, curcumin, wogonin and silibinin), alkaloids (berberine), terpenes (artemisinin, β-elemene, oridonin, triptolide, and ursolic acid), quinones (shikonin and emodin) and saponins (ginsenoside Rg3), which are isolated from Chinese medicinal herbs. In particular, the discovery of the new use of artemisinin derivatives as excellent anti-cancer drugs is also reviewed.
Article
Full-text available
Cancer prevention is effective and reduces health care costs because cancer is often a preventable disease that can be affected by lifestyle factors. Therefore, researchers are interested in discovering natural compounds that have anticancer activities, such as delaying the development of cancer and preventing its progression. One such natural agent is ginseng (Panax ginseng), which is traditionally used in some parts of the world as a popular remedy for various diseases including cancer. We hypothesized that the ginsenoside Rp1, a component of ginseng, reduces cancer cell proliferation through inhibition of the insulin-like growth factor 1 receptor (IGF-1R)/Akt pathway. We first tested the efficacy of Rp1 against human breast cancer cell lines. Treatment with Rp1 inhibited breast cancer cell proliferation and inhibited both anchorage-dependent and -independent breast cancer cell colony formation. In addition, treatment with 20 μM Rp1 induced cycle arrest and apoptosis-mediated cell growth suppression. Our findings further indicated that Rp1 decreased the stability of the IGF-1R protein in breast cancer cells. Therefore, we suggest that Rp1 has potential as an anticancer drug and that IGF-1R is an important target for treatment and prevention of breast cancer.
Article
Artemisia capillaries is a major important food and medicinal resource in Korea. In order to confirm the biological activities of Artemisia capillaries, we investigated antioxidant and anticancer activities from in vitro assays. The Artemisia capillaries methanol (MeOH) extracts was used for the evaluation of DPPH scavenging, total phenolic content, total flavonoid content, hydroxyl radical (·OH) scavenging, reducing power assay as antioxidant activity, as well as anticancer activities as MTT assay. As a result, the Artemisia capillaries MeOH extracts showed potent antioxidative activity and anticancer activity in vitro. These results suggest that the Artemisia capillaries MeOH extracts have a potential alleviated oxidation process, cell motility activity, and tumorigenesis.
Article
Utilizing a differential extraction technique for the examination of the bark of the Australian plant Acronychia Baueri Schott (Bauerella australiana Borzi), has resulted in the isolation of the triterpene lupeol and the alkaloids melicopine, acronycine, and normelicopidine. The experimental antitumor activity associated with the crude alkaloidal mixture obtained from the ether extract has been shown to be attributable to acronycine. Experimental evidence is herein given, showing acronycine to have the broadest antitumor spectrum of any alkaloid isolated to date in these laboratories. By virtue of its being chemically unrelated to any of the presently utilized antitumor agents it represents a new lead in the search for agents effective in the chemotherapeutic management of human neoplasms.
Article
We have previously demonstrated that an aqueous extract from Larrea divaricata has an antiproliferative activity on T lymphoma (BW 5147) cells in culture. Moreover the extract has in vivo antitumor activity when it was administered to a pregnant rat which had a spontaneous mammary tumor. In this work, the effect of an extract of Larrea divaricata on a mammary carcinoma chemically induced with N-nitrosomethylurea in females rats was studied. The extract was administered at a dose of 250 mg/kg three times each week by two different routes, subcutaneous (s.c.) and intratumoral (i.t.). The antitumor activity of the extract was evaluated by the survival time and the percentage of tumors that decreased, remained static or increased. From tumors treated via i.t. with the extract, 7 decreased (58%), 4 remained static (33%), and 1 increased (8%); whereas from tumors treated via s.c. with the extract, 10 decreased (12%), 59 remained static (75%) and 9 increased (11%); The total number of control tumors was 80, none of them showed regression, 12 remained static (15%) and 68 increased (85%). The survival time of treated animals using both routes (s.c. and i.t.) was significantly greater (p < 0.05) than the saline-treated rats (control): extract 70 ± 19 days, n: 32; saline (control) 38 ± 22 days, n: 20. We conclude that the aqueous extract of this plant has an in vivo antitumor activity with the intratumor route being most effective in induction of tumor regression.
Article
The in vitro inhibitory effect of Beta vulgaris (beet) root extract on Epstein-Barr virus early antigen (EBV-EA) induction using Raji cells revealed a high order of activity compared to capsanthin, cranberry, red onion skin and short and long red bell peppers. An in vivo anti-tumor promoting activity evaluation against the mice skin and lung bioassays also revealed a significant tumor inhibitory effect. The combined findings suggest that beetroot ingestion can be one of the useful means to prevent cancer.